| # | Drug | Count |
|---|---|---|
| 0 | DIAZEPAM | 16 |
| 1 | DIAZEPAM ORAL | 16 |
| 2 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 16 |
| 3 | DICLOFENAC SODIUM | 16 |
| 4 | FINGOLIMOD HCL | 16 |
| 5 | LORATADINE | 16 |
| 6 | RAMIPRIL | 16 |
| 7 | FENTANYL | 15 |
| 8 | GLUCAGON | 15 |
| 9 | LORATADINE ORAL | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRADIOL VALERATE | 14 | 0.0180 |
| 1 | GLUCAGON | 15 | 0.0035 |
| 2 | PURIXAN | 1 | 0.0013 |
| 3 | INSULIN GLULISINE | 13 | 0.0013 |
| 4 | CEFAZOLIN SODIUM | 13 | 0.0011 |
| 5 | CEFACLOR | 1 | 0.0006 |
| 6 | PEGASPARGASE | 6 | 0.0005 |
| 7 | FINGOLIMOD HYDROCHLORIDE | 2 | 0.0004 |
| 8 | TRAMADOL HYDROCHLORIDE | 12 | 0.0003 |
| 9 | MERCAPTOPURINE | 5 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Angiotensin Converting Enzyme Inhibitor [EPC] | 16 |
| 1 | Benzodiazepine [EPC] | 16 |
| 2 | Antihypoglycemic Agent [EPC] | 15 |
| 3 | Gastrointestinal Motility Inhibitor [EPC] | 15 |
| 4 | Opioid Agonist [EPC] | 15 |
| 5 | Insulin Analog [EPC] | 13 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 12 |
| 8 | Asparagine-specific Enzyme [EPC] | 6 |
| 9 | Corticosteroid [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antihypoglycemic Agent [EPC] | 15 | 0.0035 |
| 1 | Asparagine-specific Enzyme [EPC] | 6 | 0.0004 |
| 2 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |
| 3 | Angiotensin Converting Enzyme Inhibitor [EPC] | 16 | 0.0001 |
| 4 | Opioid Agonist [EPC] | 15 | 0.0001 |
| 5 | Insulin Analog [EPC] | 13 | 0.0000 |
| 6 | Azole Antifungal [EPC] | 4 | 0.0000 |
| 7 | Benzodiazepine [EPC] | 16 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 12 | 0.0000 |